XML 31 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Cash Flows from Operating Activities:    
Net income $ 9,397 $ 14,655
Operating distributions received from unconsolidated joint ventures 266 463
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation 33,727 29,684
Amortization of deferred financing costs 774 594
Settlement of forward starting interest rate swaps 14,960 0
Other amortization 14,346 8,964
Impairment loss on real estate assets 0 6,402
Stock compensation expense 636 594
Equity in loss/(income) of unconsolidated joint ventures 266 (395)
Loss on sale of real estate assets, net 106 0
Changes in assets and liabilities:    
Increase in tenant and straight-line rent receivables, net (1,371) (9,685)
Decrease in restricted cash and escrows 43 9
Increase in prepaid expenses and other assets (3,467) (171)
Decrease in accounts payable and accrued expenses (350) (11,122)
Increase in deferred income 720 2,033
Net cash provided by operating activities 70,053 42,025
Cash Flows from Investing Activities:    
Acquisition of real estate assets and related intangibles (400) (247,499)
Capitalized expenditures, net of accruals (27,187) (34,114)
Net sales proceeds from wholly-owned properties 22,322 3,403
Investments in unconsolidated joint ventures 0 (672)
Deferred lease costs paid (4,180) (7,897)
Net cash used in investing activities (9,445) (286,779)
Cash Flows from Financing Activities:    
Deferred financing costs paid (454) (47)
Proceeds from debt 764,564 294,000
Repayments of debt (737,000) (11,000)
Repurchases of common stock as part of announced plan (54,515) (11)
Dividends paid and discount on dividend reinvestments (30,905) (33,570)
Net cash (used in)/provided by financing activities (58,310) 249,372
Net increase in cash and cash equivalents 2,298 4,618
Cash and cash equivalents, beginning of period 6,973 12,957
Cash and cash equivalents, end of period 9,271 17,575
Supplemental Disclosures of Significant Noncash Investing and Financing Activities:    
Change in accrued share repurchases as part of an announced plan (1,836) 0
Accrued capital expenditures and deferred lease costs 13,721 30,994
Accrued deferred financing costs $ 176 $ 0